课题基金 / 基金详情

POSITIVE SELECTION BY SINGLE CLASS II MHC/PEPTIDE MOTIFS

POSITIVE SELECTION BY SINGLE CLASS II MHC/PEPTIDE MOTIFS
单一 II 类 MHC/肽基序的阳性选择
批准号:
2669986
负责人:
LESZEK IGNATOWICZ
金额:
$15.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2002-11-30

项目摘要

项目成果

LESZEK IGNATOWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Investigator's abstract): The overall aim of this application is to determine the significance of self-derived peptides in positive selection of CD4+ T-cells in the thymus in vivo. In the thymus, thymocytes bearing receptors that can interact with self MHC/peptide complexes are selected to mature. Furthermore, thymocytes that interact too strongly with self MHC/peptide complexes are eliminated as potentially autoaggressive. The importance of self-derived peptides in negative selection in the thymus is indisputable. The role of peptides in the process of positive selection is not as clear as it is in negative selection. Currently, there are no data that show that positive selection on natural MHC/peptide ligands is primarily peptide specific. This application uses the recently established in vivo model, in which all class II MHC molecules (Ab) are occupied by a single peptide E(52-68) (Ep), to study the specificity of CD4+ T-cells selected on this MHC/peptide complex. Experiments in Specific Aim 1 are designed to determine the repertoire and specificity of CD4+ T-cells selected by a single class II MHC/peptide complex. In particular, the investigator will study the repertoire of CD4+ T-cells that were positively selected by a single class II MHC/peptide complex and negatively selected on the same class II MHC with wild-type peptides. The specific task of Aim 2 is to isolate TCR genes that encode TCRs with identified antigen-specificity, selected in vivo on the AbEp complex. These genes will allow him to construct a TCR transgenic mouse with TCR of known specificity for both selection (AbEp) and activation (AbPCC). Finally, this transgenic TCR will be tested in mice that express different amounts of the positively selected AbEp peptide ligand. Furthermore, it will be determined whether this transgenic TCR can be positively selected by other self-derived MHC/peptide complexes or on antigenic AbPCC complex. The knowledge gained from studies in this application will provide important insight into the selection processes of CD4+ T-cells in vivo, and may provide a basis for manipulation of the T-cell repertoire - an issue of great medical importance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbiome and immunosenescence of  T cells repertoire
  • 批准号:
    10661505
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    LESZEK IGNATOWICZ
  • 依托单位:
Autoreactive CD4 T cells in healthy mice
  • 批准号:
    10170262
  • 项目类别:
  • 资助金额:
    $38.99万
  • 财政年份:
    2020
  • 负责人:
    LESZEK IGNATOWICZ
  • 依托单位:
Autoreactive CD4 T cells in healthy mice
  • 批准号:
    10621383
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    LESZEK IGNATOWICZ
  • 依托单位:
Microbiome and immunosenescence of  T cells repertoire
  • 批准号:
    10417234
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    LESZEK IGNATOWICZ
  • 依托单位:
海外基金